Benidipine, a calcium channel blocker, regulates proliferation and phenotype of vascular smooth muscle cells

Journal of Pharmacological Sciences

Volumn 100, Issue 2, 2006, Pages 149-156

  Arakawa, Emi ^a   Hasegawa, Kazuhide ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Benidipine; Differentiation; p70 S6 kinase 1; Proliferation; Smooth muscle cell

Indexed keywords

ALPHA ACTIN; BENIDIPINE; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CALPONIN 1; CONTRACTILE PROTEIN; MESSENGER RNA; MYOSIN; MYOSIN HEAVY CHAIN 1; PHOSPHOTRANSFERASE; PROTEIN P21; S6 KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; NONHUMAN; PHENOTYPE; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 33244469454     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FPJ05024X     Document Type: Article

References (33)

1. Gown AM, Tsukada T, Ross R. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis. 1986;6:601-613.
2. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
3. Hamon M, Lecluse E, Monassier JP, Grollier G, Potier JC. Pharmacological approaches to the prevention of restenosis after coronary angioplasty. Drugs Aging. 1998;13:291-301.
4. Morice MC, Serruys PW, Sousa JE, Abzaid A, Sousa JE, Colombo A, et al.; RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
5. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 2001;103:192-195.
6. Raught B, Gingras AC, Sonenberg N. The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A. 2001;98:7037-7044.
7. Lane HA, Fernandez A, Lamb NJ, Thomas G. p70s6k function is essential for G1 progression. Nature. 1993;363:170-172.
8. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995;76:412-417.
9. Braun-Dullaeus RC, Mann MJ, Seay U, Zhang I, von Der Leyen HE, Morris RE, et al. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol. 2001;21:1152-1158.
10. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999;99:2164-2170.
11. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? Eur Heart J. 1999;20:406-420.
12. Zhu L, Skoultchi AI. Coordinating cell proliferation and differentiation. Curr Opin Genet Dev. 2001;11:91-97.
13. Martin KA, Rzucidlo EM, Merenick BL, Fingar DC, Brown DJ, Wagner RJ, et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol. 2004;286:C507-C517.
14. Ide S, Kondoh M, Satoh H, Karasawa A. Anti-proliferative effects of benidipine hydrochloride in porcine cultured vascular smooth muscle cells and in rats subjected to balloon catheterinduced endothelial denudation. Biol Pharm Bull. 1994;17:627-631.
15. Ide S, Kondoh M, Satoh H, Karasawa A. Inhibitory action of benidipine on balloon catheterization-induced intimal thickening of the carotid artery in rats. Jpn J Pharmacol. 1994;65:89-92.
16. Hasegawa K, Arakawa E, Oda S, Yanai N, Obinata M, Matsuda Y. Novel smooth muscle cell lines from transgenic mice harboring temperature-sensitive SV40 large T-antigen gene. Temperature-dependent expression of smooth muscle myosin heavy chain-1 and calponin genes. J Mol Cell Cardiol. 1997;29:2177-2186.
17. Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR. Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis. 1989;9:633-643.
18. Laemmli UK. Cleavage of structural proteins during the assenbly of the head of bacteriophage T4. Nature. 1970;22:680-685.
19. Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem. 1991;266:3768-3773.
20. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
21. Arakawa E, Hasegawa K, Irie J, Ide S, Ushiki J, Yamaguchi K, et al. L-Ascorbic acid stimulates expression of smooth musclespecific markers in smooth muscle cells both in vitro and in vivo. J Cardiovasc Pharmacol. 2003;42:745-751.
22. Zhang H, Hannon GJ, Beach D. p21-Containing cyclin kinases exist in both active and inactive states. Genes Dev. 1994;8:1750-1758.
23. Chang MW, Barr E, Lu MM, Barton K, Leider JM. Adenovirusmediated over-expression of the cyclin /cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest. 1995;96:2260-2268.
24. Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A. 1996;93:7905-7910.
25. 3H] benidipine hydrochloride to rat heart membranes. J Cardiovasc Pharmacol. 1993;21:191-196.
26. Yamada H, Tsushima T, Murakami H, Uchigata Y, Iwamoto Y. Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells. Int J Exp Diabetes Res. 2002;3:131-144.
27. Yellaturu CR, Bhanoori M, Neeli I, Rao GN. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem. 2002;18;277:40148-40155.
28. Iwasaki H, Eguchi S, Ueno H, Marumo F, Hirata Y. Endothelinmediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor. Endocrinology. 1999;140:4659-4668.
29. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM. Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol. 2002;62:772-777.
30. Li N, Wu KG, Wang XY, Xie LD, Xu CS, Wang HJ. Angiotensin II stimulates phosphorylation of 4E-binding protein 1 and p70 S6 kinase in cultured vascular smooth muscle cells. Acta Pharmacol Sin. 2004;25:593-596.
31. Koyama H, Olson NE, Dastvan FF, Reidy MA. Cell replication in the arterial wall: activation of signaling pathway following in vivo injury. Circ Res. 1998;82:713-721.
32. Mourani PM, Garl PJ, Wenzlau JM, Carpenter TC, Stenmark KR, Weiser-Evans MC. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Circulation. 2004;109:1299-1306.
33. 2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension. 2003;41:963-967.